Published in Int J Obstet Anesth on April 01, 1998
A survey of postoperative nausea and vomiting. Anaesthesia (1997) 3.75
Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand (2009) 1.68
Streptococcus salivarius meningitis after spinal anesthesia. Anesthesiology (1998) 1.52
Ephedrine and phenylephrine for the treatment of maternal hypotension in a chronic sheep model of increased placental vascular resistance. Br J Anaesth (2005) 1.48
Pharmacokinetics of 0.5% levobupivacaine following ilioinguinal-iliohypogastric nerve blockade in children. Acta Anaesthesiol Scand (2005) 1.39
The anti-emetic efficacy of a combination of ondansetron and droperidol. Anaesthesia (1997) 1.39
Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res (1995) 1.19
p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol (1993) 1.09
Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch A Pathol Anat Histopathol (1992) 1.09
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites. Br J Cancer (2001) 1.03
Breast-feeding problems after epidural analgesia for labour: a retrospective cohort study of pain, obstetrical procedures and breast-feeding practices. Int J Obstet Anesth (2004) 1.01
Systemic availability of ergotamine tartrate after three successive doses and during continuous medication. Eur J Clin Pharmacol (1979) 1.01
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol (1993) 0.99
Evoked EEG patterns during burst suppression with propofol. Br J Anaesth (2004) 0.97
Comparison of remifentanil and nitrous oxide in labour analgesia. Acta Anaesthesiol Scand (2005) 0.97
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide. Eur J Clin Pharmacol (1985) 0.97
Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol (2002) 0.95
Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block. Acta Anaesthesiol Scand (2000) 0.93
Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch A Pathol Anat Histopathol (1992) 0.93
Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity. J Pathol (1997) 0.92
Intravenous remifentanil vs. epidural levobupivacaine with fentanyl for pain relief in early labour: a randomised, controlled, double-blinded study. Acta Anaesthesiol Scand (2007) 0.92
Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate (2001) 0.92
Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta. Acta Anaesthesiol Scand (1997) 0.90
Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax (1996) 0.90
Ovarian toxicity of cigarette smoke exposure during pregnancy in mice. Toxicol Lett (1985) 0.90
Pharmacokinetics of 0.2% ropivacaine and 0.2% bupivacaine following caudal blocks in children. Acta Anaesthesiol Scand (2000) 0.90
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. Br J Clin Pharmacol (1995) 0.90
Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. Eur J Pharmacol (1993) 0.90
Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration. Eur J Clin Pharmacol (1979) 0.89
p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. J Pathol (1992) 0.89
p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis (1995) 0.89
Chloropicrin induces endoplasmic reticulum stress in human retinal pigment epithelial cells. Toxicol Lett (2012) 0.88
Expression of p53 protein before and after PUVA treatment in psoriasis. Acta Derm Venereol (1999) 0.88
Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS (1995) 0.86
Glutathione conjugation by isolated lung cells and the isolated, perfused lung. Effect of extracellular glutathione. Eur J Biochem (1984) 0.86
p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer (1995) 0.86
Improving the quality of postoperative pain relief. Eur J Pain (2000) 0.85
p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations. Pathol Biol (Paris) (1997) 0.85
p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke. Am J Respir Crit Care Med (1994) 0.85
Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis (1994) 0.85
Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma. Histopathology (1994) 0.84
Feasibility of a laryngeal tube for airway management during cardiac arrest by first responders. Resuscitation (2012) 0.84
Topographic electroencephalogram in children during mask induction of anaesthesia with sevoflurane. Acta Anaesthesiol Scand (2008) 0.84
Effect of crystalloid and colloid preloading on uteroplacental and maternal haemodynamic state during spinal anaesthesia for caesarean section. Br J Anaesth (1995) 0.83
Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer (1998) 0.83
Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2. Cancer Genet Cytogenet (1999) 0.83
Pharmacokinetics of 0.75% ropivacaine and 0.5% bupivacaine after ilioinguinal-iliohypogastric nerve block in children. Br J Anaesth (2002) 0.82
Effects of ephedrine and phenylephrine on uterine and placental circulations and fetal outcome following fetal hypoxaemia and epidural-induced hypotension in a sheep model. Br J Anaesth (2004) 0.82
Effect of five structurally diverse H2-receptor antagonists on drug metabolism. Biochem Pharmacol (1986) 0.82
Does ephedrine influence newborn neurobehavioural responses and spectral EEG when used to prevent maternal hypotension during caesarean section? Acta Anaesthesiol Scand (1990) 0.82
Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital. Biochem Pharmacol (1988) 0.82
Thapsigargin has similar effect on p53 protein response to benzo[a]pyrene-DNA adducts as TPA in mouse skin. Carcinogenesis (1999) 0.82
Ambient and biological monitoring of exposure to polycyclic aromatic hydrocarbons at a coking plant. Sci Total Environ (1997) 0.81
Half-life of tolbutamide in patients with chronic respiratory failure. Eur J Clin Pharmacol (1971) 0.81
Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol (1983) 0.81
Crocidolite asbestos causes an induction of p53 and apoptosis in cultured A-549 lung carcinoma cells. Apoptosis (1998) 0.81
Ethical aspects in placental perfusion studies: views of the researchers. Placenta (2011) 0.81
Aberrant p53 protein expression in cervical intra-epithelial neoplasia. Histopathology (1993) 0.81
Spectral entropy--what has it to do with anaesthesia, and the EEG? Br J Anaesth (2004) 0.81
p53 expression in lymphatic malignancies. J Clin Pathol (1992) 0.80
Cigarette smoking and drug metabolism. Clin Pharmacol Ther (1983) 0.80
An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam. J Pharmacol Toxicol Methods (2004) 0.80
Cadmium inhibits ABCG2 transporter function in BeWo choriocarcinoma cells and MCF-7 cells overexpressing ABCG2. Placenta (2012) 0.80
DNA damage caused by benzo(a)pyrene in MCF-7 cells is increased by verapamil, probenecid and PSC833. Toxicol Lett (2006) 0.80
Ethical aspects of human placental perfusion: interview of the mothers donating placenta. Placenta (2010) 0.80
Divergent effects of ephedrine and phenylephrine on cardiovascular hemodynamics of near-term fetal sheep exposed to hypoxemia and maternal hypotension. Acta Anaesthesiol Scand (2007) 0.80
Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia (2001) 0.80
Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia (1997) 0.80
Benzo[a]pyrene-DNA-adducts and monooxygenase activities in mice treated with benzo[a]pyrene, cigarette smoke or cigarette smoke condensate. Chem Biol Interact (1989) 0.80
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men. Clin Pharmacol Ther (1994) 0.80
p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions. Virchows Arch (1994) 0.80
Placental transfer and hormonal effects of metoclopramide. Eur J Clin Pharmacol (1983) 0.80
Tibial nerve somatosensory evoked potentials during EEG suppression in sevoflurane anaesthesia. Clin Neurophysiol (1999) 0.80
Effect of long-term fenfluramine treatment on drug-metabolism in rat. Experientia (1973) 0.79
p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer (1993) 0.79
Comparison of ondansetron and droperidol in the prevention of postoperative nausea and vomiting after laparoscopic surgery in women. A randomised, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand (1997) 0.79
p53 immunohistochemical positivity as a prognostic marker in intracranial tumours. APMIS (1994) 0.79
Survey of acute poisoning cases in North-Finland during 1973-1982. Toxicol Lett (1984) 0.79
Genetic and environmental regulation of aryl hydrocarbon hydroxylase in man: studies with liver, lung, placenta, and lymphocytes. Toxicol Pathol (1984) 0.79
Effect of carbon tetrachloride induced progressive liver damage on drug-metabolizing enzymes and cytochrome P-450 in rat liver. Acta Pharmacol Toxicol (Copenh) (1971) 0.79
TPA decreases the p53 response to benzo[a]pyrene-DNA adducts in vivo in mouse skin. Carcinogenesis (1996) 0.79
3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutat Res (1999) 0.79
Benzo[a]pyrene-globin adducts detected by synchronous fluorescence spectrophotometry: method development and relation to lung DNA adducts in mice. Carcinogenesis (1991) 0.78
Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam. Clin Pharmacol Ther (1985) 0.78
p53 status of newly established acute myeloid leukaemia cell lines. Br J Cancer (1999) 0.78
Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice. Biochem Pharmacol (1992) 0.78
Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand (2009) 0.78
Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarean section. Int J Obstet Anesth (1997) 0.78
Clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% bupivacaine in peribulbar anaesthesia for cataract surgery. Anaesthesia (1999) 0.78
Maternal and uteroplacental haemodynamic state in pre-eclamptic patients during spinal anaesthesia for Caesarean section. Br J Anaesth (1996) 0.78
The DNA binding of benzo[alpha]pyrene metabolites catalysed by rat lung microsomes in vitro and in isolated perfused rat lung. Chem Biol Interact (1979) 0.78
Comparison between cobalt and pyrazole in the increased expression of coumarin 7-hydroxylase in mouse liver. Biochem Pharmacol (1991) 0.77
Alterations of rat serum lipoproteins and lecithin-cholesterol-acyltransferase activity in praseodymium-induced liver damage. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.77
Genetic analysis of metabolic polymorphisms in molecular epidemiological studies: social and ethical implications. IARC Sci Publ (1999) 0.77
Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses. Ups J Med Sci Suppl (1980) 0.77
3,4-Benzpyrene and N-methylaniline metabolizing enzymes in the immature human foetus and placenta. Acta Pharmacol Toxicol (Copenh) (1971) 0.77
The metabolism of benzo(a)pyrene in isolated perfused lungs from variously-treated rats. Acta Pharmacol Toxicol (Copenh) (1977) 0.77